Literature DB >> 7890219

Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.

W Uddin1, J K Ramage, B Portmann, P Wilson, I Benjamin, K C Tan, R Williams.   

Abstract

Polycystic liver disease is commonly asymptomatic but may present with hepatomegaly, abdominal distension, and dull abdominal pain. Transudative ascites is a rare manifestation in these patients but may occur when portal hypertension is present resulting from associated hepatic fibrosis or after deroofing procedure of a cyst. Exudative ascites might suggest hepatic venous outflow obstruction. Four cases are described where hepatic venous outflow obstruction occurred in patients with polycystic liver disease. Three patients had orthotopic liver transplantation and one had a mesocaval shunt. Of the two patients that survived orthotopic liver transplantation both have shown considerable improvement in their symptoms. None of the patients had any confirmed procoagulant disorder. The mechanism of hepatic venous outflow obstruction in these patients seems to be mechanical compression of hepatic veins by the cysts and associated formation of thrombi in small hepatic vein tributaries. Patients with severe polycystic kidney/liver disease are at risk of hepatic venous outflow obstruction and the onset of this complication is heralded by tender hepatomegaly and presence of exudative ascites.

Entities:  

Mesh:

Year:  1995        PMID: 7890219      PMCID: PMC1382369          DOI: 10.1136/gut.36.1.142

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Polycystic liver; analysis of seventy cases.

Authors:  P J MELNICK
Journal:  AMA Arch Pathol       Date:  1955-02

2.  Clinical experience with adult polycystic liver disease.

Authors:  J N Vauthey; G J Maddern; P Kolbinger; H U Baer; L H Blumgart
Journal:  Br J Surg       Date:  1992-06       Impact factor: 6.939

3.  Highly symptomatic adult polycystic disease of the liver. A report of fifteen cases.

Authors:  K J van Erpecum; A R Janssens; J L Terpstra; R T Tjon A Tham
Journal:  J Hepatol       Date:  1987-08       Impact factor: 25.083

4.  Liver transplantation for polycystic liver disease.

Authors:  T E Starzl; J Reyes; A Tzakis; L Mieles; S Todo; R Gordon
Journal:  Arch Surg       Date:  1990-05

5.  Liver cysts in patients with autosomal dominant polycystic kidney disease.

Authors:  J Milutinovic; P J Fialkow; T G Rudd; L Y Agodoa; L A Phillips; J I Bryant
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

6.  Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study.

Authors:  E Levine; L T Cook; J J Grantham
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

7.  Budd-Chiari syndrome in association with polycystic disease of the liver and kidneys.

Authors:  A Bhupalan; K Talbot; A Forbes; M Owen; D Samson; I M Murray-Lyon
Journal:  J R Soc Med       Date:  1992-05       Impact factor: 18.000

  7 in total
  13 in total

1.  Intra-operative inferior vena cava syndrome in a patient with autosomal dominant polycystic kidney disease.

Authors:  S A Pierre; M T Jaeger; D R Siemens
Journal:  World J Urol       Date:  2006-01-25       Impact factor: 4.226

2.  Liver Failure in Advanced Adult-onset Polycystic Kidney Disease.

Authors:  Christina Awad; Grant Gardner Gallimore
Journal:  BMJ Case Rep       Date:  2018-04-13

Review 3.  Management of polycystic liver disease.

Authors:  Gregory T Everson; Matthew R G Taylor
Journal:  Curr Gastroenterol Rep       Date:  2005-02

4.  Polycystic liver: automatic segmentation using deep learning on CT is faster and as accurate compared to manual segmentation.

Authors:  Bénédicte Cayot; Laurent Milot; Olivier Nempont; Anna S Vlachomitrou; Carole Langlois-Jacques; Jérôme Dumortier; Olivier Boillot; Karine Arnaud; Thijs R M Barten; Joost P H Drenth; Pierre-Jean Valette
Journal:  Eur Radiol       Date:  2022-02-10       Impact factor: 5.315

5.  A Rare Cause of Cholestasis Related to Polycystic Liver Disease.

Authors:  Pedro Costa-Moreira; Susana Lopes; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2021-02-12

Review 6.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

7.  Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease.

Authors:  Jayleen Grams; Swee H Teh; Vicente E Torres; James C Andrews; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

8.  Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.

Authors:  Neil Rajoriya; Dhiraj Tripathi; Joanna A Leithead; Bridget K Gunson; Sophie Lord; James W Ferguson; Gideon M Hirschfield
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

9.  Functional Budd-Chiari Syndrome Associated With Severe Polycystic Liver Disease.

Authors:  Precil Diego Miranda de Menezes Neves; Bruno Eduardo Pedroso Balbo; Elieser Hitoshi Watanabe; Vinicius Rocha-Santos; Wellington Andraus; Luiz Augusto Carneiro D'Albuquerque; Luiz Fernando Onuchic
Journal:  Clin Med Insights Gastroenterol       Date:  2017-06-07

Review 10.  Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Authors:  Wybrich R Cnossen; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2014-05-01       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.